← Back
$URGN All transactions

UroGen Pharma Ltd.

▼ SELL 10b5-1 Plan

$ Value

$250K

Shares

10,000

Price

$25

Filed

Nov 20

Insider

Name

Schoenberg Mark

Title

Chief Medical Officer

CIK

0001763581

Roles

Officer

Transaction Details

Transaction Date

2025-11-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

139,025

Footnotes

Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 and $25.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Filing Info

Accession No.

0001437749-25-035821

Form Type

4

Issuer CIK

0001668243

Schoenberg Mark's History

Date Ticker Type Value
2026-02-03 URGN $36K
2026-02-03 URGN $36K
2026-02-03 URGN $73K
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN A $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03